A rare population of tumor antigen-specific CD4+CD8+ double-positive αβ T lymphocytes uniquely provide CD8-independent TCR genes for engineering therapeutic T cells-Reference-Cited by-同舟云学术

A rare population of tumor antigen-specific CD4+CD8+ double-positive αβ T lymphocytes uniquely provide CD8-independent TCR genes for engineering therapeutic T cells

Published:2019-01-09 Issue:1 Volume:7 Page:
ISSN:2051-1426
Container-title:Journal for ImmunoTherapy of Cancer
language:en
Short-container-title:j. immunotherapy cancer

Author:

Matsuzaki Junko,Tsuji Takemasa,Chodon Thinle,Ryan Courtney,Koya Richard C.,Odunsi Kunle

Funder

Ovarian Cancer Research Fund

Roswell Park Alliance Foundation, Roswell Park Cancer Institute

National Cancer Institute

National Institutes of Health

New York State Department of Health

Publisher

BMJ

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1186/s40425-018-0467-y.pdf

Reference45 articles.

1. Robbins PF, Morgan RA, Feldman SA, Yang JC, Sherry RM, Dudley ME, et al. Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. J Clin Oncol. 2011;29:917–24.

2. Chodon T, Comin-Anduix B, Chmielowski B, Koya RC, Wu Z, Auerbach M, et al. Adoptive transfer of MART-1 T-cell receptor transgenic lymphocytes and dendritic cell vaccination in patients with metastatic melanoma. Clin Cancer Res. 2014;20:2457–65.

3. Kageyama S, Ikeda H, Miyahara Y, Imai N, Ishihara M, Saito K, et al. Adoptive transfer of MAGE-A4 T-cell receptor gene-transduced lymphocytes in patients with recurrent esophageal Cancer. Clin Cancer Res. 2015;21:2268–77.

4. Zhao Y, Bennett AD, Zheng Z, Wang QJ, Robbins PF, Yu LY, et al. High-affinity TCRs generated by phage display provide CD4+ T cells with the ability to recognize and kill tumor cell lines. J Immunol. 2007;179:5845–54.

5. Tan MP, Dolton GM, Gerry AB, Brewer JE, Bennett AD, Pumphrey NJ, et al. Human leucocyte antigen class I-redirected anti-tumour CD4+ T cells require a higher T cell receptor binding affinity for optimal activity than CD8+ T cells. Clin Exp Immunol. 2017;187:124–37.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptide-functionalized zinc oxide nanoparticles for the selective targeting of breast cancer expressing placenta-specific protein 1;Colloids and Surfaces B: Biointerfaces;2023-07

2. miR-4433a-3p promotes granulosa cell apoptosis by targeting peroxisome proliferator–activated receptor alpha and inducing immune cell infiltration in polycystic ovarian syndrome;Journal of Assisted Reproduction and Genetics;2023-05-19

3. Peptide-functionalized graphene oxide quantum dots as colorectal cancer theranostics;Journal of Colloid and Interface Science;2023-01

4. Role of immunotherapy in ovarian cancer: a narrative review;Gynecology and Pelvic Medicine;2022-12

5. Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction;Cancer Immunology, Immunotherapy;2022-04-23